Literature DB >> 227893

Studies of the electron-nuclear coupling between Fe(III) and 14N in cytochrome P-450 and in a series of low spin heme compounds.

J Peisach, W B Mims, J L Davis.   

Abstract

We have observed the nuclear modulation pattern in the envelope of electron spin echoes for various low spin paramagnetic heme proteins including cytochrome c, myoglobin hydroxide, myoglobin mercaptoethanol, and cytochrome P-450, using the three-pulse-stimulated echo method. We have also carried out similar experiments with model compounds containing either [14N]- or [15N]imidazole. In many of the compounds studied, we have been able to identify the nuclear modulation effects arising from 14N of the porphyrin ring and have been able to characterize and interpret the modulation effects due to 14N of various nitrogenous axial ligands. We have found that the heme of low spin ferric cytochrome P-450 is coordinated to a nitrogenous ligand, probably imidazole. We have also demonstrated that the remote 14N of the imidazole ligand in a [14N]imidazole-heme-NO-model compound is coupled differently than in myoglobin nitroxide, demonstrating the direct effect of the protein of metal ligand bonding.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 227893

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  2 in total

1.  Designing inhibitors of cytochrome c/cardiolipin peroxidase complexes: mitochondria-targeted imidazole-substituted fatty acids.

Authors:  Jianfei Jiang; Ahmet Bakan; Alexandr A Kapralov; K Ishara Silva; Zhentai Huang; Andrew A Amoscato; James Peterson; Venkata Krishna Garapati; Sunil Saxena; Hülya Bayir; Jeffrey Atkinson; Ivet Bahar; Valerian E Kagan
Journal:  Free Radic Biol Med       Date:  2014-03-12       Impact factor: 7.376

2.  The accessibility of type I Cu(II) centers in laccase, azurin, and stellacyanin to exchangeable hydrogen and ambient water.

Authors:  W B Mims; J L Davis; J Peisach
Journal:  Biophys J       Date:  1984-04       Impact factor: 4.033

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.